论文部分内容阅读
严重急性呼吸综合征(SARS)是一种人类目前尚未认识的新型烈性传染病。其发现机制及治疗在目前仍处于探索阶段。抑制机体免疫损伤的糖皮质激素治疗SARS已被临床认为是一种有效的治疗方法[1 ] 。我院在救治SARS的过程中,结合北京、广州等地的治疗经验,试验性地将胸腺肽与甲泼尼龙
Severe Acute Respiratory Syndrome (SARS) is a new type of potent infectious disease that humans have not known yet. Its discovery mechanism and treatment are still in the exploratory stage at present. Inhibition of immune damage of glucocorticoid treatment of SARS has been clinically considered an effective treatment [1]. Our hospital in the treatment of SARS in the process, combined with Beijing, Guangzhou and other places of treatment experience, thymosin and methylprednisolone